Dendritic Cells and Programmed Death-1 Blockade: A Joint Venture to Combat Cancer

por Versteven, Maarten, Van den Bergh, Johan M. J., Marcq, Elly, Smits, Evelien L. J., Van Tendeloo, Viggo F. I., Hobo, Willemijn, Lion, Eva
Publicado 2018

Interleukin-15 enhances the proliferation, stimulatory phenotype, and antitumor effector functions of human gamma delta T cells

por Van Acker, Heleen H., Anguille, Sébastien, Willemen, Yannick, Van den Bergh, Johan M., Berneman, Zwi N., Lion, Eva, Smits, Evelien L., Van Tendeloo, Viggo F.
Publicado 2016

Efficient and Non-genotoxic RNA-Based Engineering of Human T Cells Using Tumor-Specific T Cell Receptors With Minimal TCR Mispairing

por Campillo-Davo, Diana, Fujiki, Fumihiro, Van den Bergh, Johan M. J., De Reu, Hans, Smits, Evelien L. J. M., Goossens, Herman, Sugiyama, Haruo, Lion, Eva, Berneman, Zwi N., Van Tendeloo, Viggo
Publicado 2018

HPV vaccine stimulates cytotoxic activity of killer dendritic cells and natural killer cells against HPV-positive tumour cells

por Van den Bergh, Johan M J, Guerti, Khadija, Willemen, Yannick, Lion, Eva, Cools, Nathalie, Goossens, Herman, Vorsters, Alex, Van Tendeloo, Viggo F I, Anguille, Sébastien, Van Damme, Pierre, Smits, Evelien L J M
Publicado 2014

Desirable cytolytic immune effector cell recruitment by interleukin-15 dendritic cells

por Van Acker, Heleen H., Beretta, Ottavio, Anguille, Sébastien, Caluwé, Lien De, Papagna, Angela, Van den Bergh, Johan M., Willemen, Yannick, Goossens, Herman, Berneman, Zwi N., Van Tendeloo, Viggo F., Smits, Evelien L., Foti, Maria, Lion, Eva
Publicado 2017

Interleukin-15 stimulates natural killer cell-mediated killing of both human pancreatic cancer and stellate cells

por Van Audenaerde, Jonas R.M., De Waele, Jorrit, Marcq, Elly, Van Loenhout, Jinthe, Lion, Eva, Van den Bergh, Johan M.J., Jesenofsky, Ralf, Masamune, Atsushi, Roeyen, Geert, Pauwels, Patrick, Lardon, Filip, Peeters, Marc, Smits, Evelien L.J.
Publicado 2017

A versatile T cell-based assay to assess therapeutic antigen-specific PD-1-targeted approaches

por Versteven, Maarten, Van den Bergh, Johan M.J., Broos, Katrijn, Fujiki, Fumihiro, Campillo-Davo, Diana, De Reu, Hans, Morimoto, Soyoko, Lecocq, Quentin, Keyaerts, Marleen, Berneman, Zwi, Sugiyama, Haruo, Van Tendeloo, Viggo F.I., Breckpot, Karine, Lion, Eva
Publicado 2018

The tumor-associated antigen RHAMM (HMMR/CD168) is expressed by monocyte-derived dendritic cells and presented to T cells

por Willemen, Yannick, Van den Bergh, Johan M.J., Bonte, Sarah M., Anguille, Sébastien, Heirman, Carlo, Stein, Barbara M.H., Goossens, Herman, Kerre, Tessa, Thielemans, Kris, Peeters, Marc, Van Tendeloo, Viggo F.I., Smits, Evelien L.J., Berneman, Zwi N.
Publicado 2016